sb 203580 has been researched along with angiotensinogen in 1 studies
Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (angiotensinogen) | Trials (angiotensinogen) | Recent Studies (post-2010) (angiotensinogen) |
---|---|---|---|---|---|
3,489 | 4 | 1,137 | 3,606 | 78 | 875 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chan, JS; Chen, X; Filep, JG; Ingelfinger, JR; Tang, SS; Zhang, SL | 1 |
1 other study(ies) available for sb 203580 and angiotensinogen
Article | Year |
---|---|
High levels of glucose stimulate angiotensinogen gene expression via the P38 mitogen-activated protein kinase pathway in rat kidney proximal tubular cells.
Topics: Angiotensinogen; Animals; Blotting, Western; Deoxyglucose; Enzyme Activation; Enzyme Inhibitors; Gene Expression; Glucose; Imidazoles; Kidney Tubules, Proximal; Mannitol; Mitogen-Activated Protein Kinases; Phosphorylation; Pyridines; Rats; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Sorbitol; Tetradecanoylphorbol Acetate | 2000 |